EUCTR2014-002407-25-BE进行中（未招募）1 期
A Phase 4 long-term follow-up study to define the safety profile of radium-223 dichloride - Radium-223 dichloride long-term follow-up program
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Bayer AG
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subject was previously enrolled in a selected company-sponsored feeder trial, and has received at least 1 dose of radium-223 dichloride or placebo in the feeder trial.
- •2. Written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 400
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 400
排除标准
- •Not applicable for this study
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to assess the long term safety of radium-223 dichlorideCastrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer patients with bone metastasisMedDRA version: 20.1Level: LLTClassification code 10036916Term: Prostate cancer stage DSystem Organ Class: 100000004864EUCTR2014-002407-25-ESBayer AG800
进行中（未招募）
1 期
A clinical trial to assess the long term safety of radium-223 dichlorideCastrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer, breast cancer or multiple myeloma patients with bone metastasisMedDRA version: 20.1Level: LLTClassification code 10036916Term: Prostate cancer stage DSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-002407-25-DEBayer AG800
进行中（未招募）
1 期
A clinical trial to assess the long term safety of radium-223 dichlorideEUCTR2014-002407-25-GBBayer AG800
进行中（未招募）
1 期
A clinical trial to assess the long term safety of radium-223 dichlorideCastrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer, breast cancer or multiple myeloma patients with bone metastasisMedDRA version: 20.1Level: LLTClassification code 10036916Term: Prostate cancer stage DSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-002407-25-PLBayer AG800
进行中（未招募）
1 期
A clinical trial to assess the long term safety of radium-223 dichlorideEUCTR2014-002407-25-FRBayer AG800